This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Lts Lohmann Therapie-Systeme Ag, New Jersey Institute of Technology. Active years: 2022-2025.
Company Filing History:
2 out of 333 
1 out of 387 
Years Active: 2022-2025
Title: James Paul Ronnander: Innovator in Microneedle Technology
Introduction
James Paul Ronnander is a notable inventor based in Mount Vernon, NY (US). He has made significant contributions to the field of medical technology, particularly in the development of microneedle devices. With a total of 2 patents, Ronnander's work focuses on enhancing drug delivery systems.
Latest Patents
Ronnander's latest patents include a microneedle array comprising a heat-producing element. This invention relates to a microneedle array that features a heat-generating element, which is used for the intradermal application of active ingredients, especially active pharmaceutical ingredients (API) and drugs. The microneedle array is designed for skin penetration in humans or animals, utilizing a water-soluble formulation that contains at least one active ingredient. Another significant patent is the iontophoretic microneedle device, which is a medical drug device for transdermal drug delivery systems (TDDS). This device comprises a novel iontophoretic polymeric microneedle and is utilized in the administration of drugs.
Career Highlights
Throughout his career, Ronnander has worked with reputable organizations, including LTS Lohmann Therapie-Systeme AG and the New Jersey Institute of Technology. His experience in these institutions has contributed to his expertise in microneedle technology and drug delivery systems.
Collaborations
Ronnander has collaborated with notable professionals in his field, including Laurent Simon and Andreas Koch. These collaborations have furthered the development of innovative solutions in medical technology.
Conclusion
James Paul Ronnander is a distinguished inventor whose work in microneedle technology has the potential to revolutionize drug delivery systems. His patents reflect a commitment to advancing medical applications for improved patient care.